Wenatchee Valley Medical Center Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2005
NCT00109161
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Wenatchee Valley Medical Center, Clinical Research Department

Active Ingredients

Drugs in Phase 3 Trials (1)

cd07805/47 (1 trial)

Drugs in Phase 2 Trials (2)

daclizumab (Zenapax) (1 trial)

nb-001 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Erythema (Phase 3)

Herpes Labialis (Phase 2)

Multiple Sclerosis (Phase 2)

Rosacea (Phase 3)

Sclerosis (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3